Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$1.10
$1.21
$0.84
$2.03
$41.94M1.05115,636 shs38,137 shs
CZX
Canada Zinc Metals
C$0.31
+∞
C$0.31
C$0.22
C$0.39
C$51.69MN/A238,645 shs118,500 shs
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$20.86
C$18.60
C$22.79
N/AN/A468,009 shs3.04 million shs
GP Strategies Co. stock logo
GPX
GP Strategies
$20.85
$20.76
$9.36
$20.93
$365.94M1.64109,783 shs396,192 shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-1.79%-5.17%-21.43%0.00%-32.93%
CZX
Canada Zinc Metals
0.00%0.00%0.00%0.00%0.00%
First Capital Realty Inc. stock logo
FCR
First Capital Realty
0.00%0.00%0.00%0.00%0.00%
GP Strategies Co. stock logo
GPX
GP Strategies
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
2.0954 of 5 stars
3.50.00.00.01.73.31.3
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/AN/AN/AN/A
GP Strategies Co. stock logo
GPX
GP Strategies
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
3.00
Buy$7.00536.36% Upside
CZX
Canada Zinc Metals
N/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/A
GP Strategies Co. stock logo
GPX
GP Strategies
N/AN/AN/AN/A

Current Analyst Ratings

Latest GPX, BOLT, CZX, and FCR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/22/2024
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$8.00
(Data available from 5/3/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$7.88M5.32N/AN/A$2.97 per share0.37
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/AN/A
GP Strategies Co. stock logo
GPX
GP Strategies
$473.11M0.77$1.20 per share17.34$13.01 per share1.60

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-$69.20M-$1.83N/AN/AN/A-878.58%-51.18%-37.81%5/9/2024 (Estimated)
CZX
Canada Zinc Metals
N/AN/A0.00N/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/A0.00N/AN/AN/AN/AN/A8/6/2024 (Estimated)
GP Strategies Co. stock logo
GPX
GP Strategies
$7.07M$0.7328.5617.381.322.73%9.09%5.38%N/A

Latest GPX, BOLT, CZX, and FCR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/21/2024Q4 2023
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-$0.47-$0.47N/A-$0.47$1.97 million$2.09 million
2/6/2024Q4 2023
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$0.31C$0.81+C$0.50C$0.81N/AC$171.18 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
N/AN/AN/AN/AN/A
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/A
GP Strategies Co. stock logo
GPX
GP Strategies
N/AN/AN/AN/AN/A

Latest GPX, BOLT, CZX, and FCR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/15/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.074.14%4/29/20244/30/20245/15/2024
3/15/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.073/27/20243/28/20244/15/2024
2/6/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.072/28/20242/29/20243/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
0.15
5.17
5.17
CZX
Canada Zinc Metals
N/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/A
GP Strategies Co. stock logo
GPX
GP Strategies
0.04
1.97
1.97

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
86.70%
CZX
Canada Zinc Metals
N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/A
GP Strategies Co. stock logo
GPX
GP Strategies
61.97%

Insider Ownership

CompanyInsider Ownership
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
28.40%
CZX
Canada Zinc Metals
N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/A
GP Strategies Co. stock logo
GPX
GP Strategies
25.00%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
10038.13 million27.30 millionNot Optionable
CZX
Canada Zinc Metals
147,000166.73 millionN/ANot Optionable
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/ANot Optionable
GP Strategies Co. stock logo
GPX
GP Strategies
4,34317.55 millionN/AOptionable

GPX, BOLT, CZX, and FCR Headlines

SourceHeadline
Stella defends McLaren F1 team strategy in “complex” Japanese GPStella defends McLaren F1 team strategy in “complex” Japanese GP
msn.com - April 9 at 8:27 PM
Stroll: Wrong wing and ‘sub-optimal strategy’ ruined Japanese GPStroll: Wrong wing and ‘sub-optimal strategy’ ruined Japanese GP
f1i.com - April 9 at 8:27 PM
Japanese GP data: What we learned from practice at SuzukaJapanese GP data: What we learned from practice at Suzuka
msn.com - April 5 at 10:33 AM
Competitive StrategiesCompetitive Strategies
digitaltransactions.net - April 4 at 2:30 PM
Bootstrapping Definition, Strategies, and Pros/ConsBootstrapping Definition, Strategies, and Pros/Cons
investopedia.com - March 28 at 2:09 AM
Free F1 live stream: Where to watch every Formula 1 GP race weekend from anywhereFree F1 live stream: Where to watch every Formula 1 GP race weekend from anywhere
businessinsider.com - March 23 at 12:33 AM
Honda MotoGP development not being focused on Marquez helping everyone - ZarcoHonda MotoGP development not being focused on Marquez helping everyone - Zarco
msn.com - March 17 at 1:57 AM
Ambient Scientifics Edge AI Processor goes into volume productionAmbient Scientific's Edge AI Processor goes into volume production
finance.yahoo.com - January 4 at 7:09 PM
GP Strategies Joins Forces with Quantum5 to Transform Automotive Retail Industry SupportGP Strategies Joins Forces with Quantum5 to Transform Automotive Retail Industry Support
finance.yahoo.com - January 3 at 12:15 PM
GPX Unveils Limited Japan-Only GTM250R Cafe RacerGPX Unveils Limited Japan-Only GTM250R Cafe Racer
msn.com - December 27 at 10:44 PM
Support Single PayerSupport Single Payer
gp.org - December 18 at 8:41 AM
How Game Theory Strategy Improves Decision-MakingHow Game Theory Strategy Improves Decision-Making
investopedia.com - December 13 at 11:39 PM
GPT-4’s secret weapon is available as open sourceGPT-4’s 'secret weapon' is available as open source
msn.com - December 11 at 6:12 PM
10 Best Gpx Radio Cd Players10 Best Gpx Radio Cd Players
recombu.com - December 2 at 10:07 AM
10 MotoGP Innovations That Changed The Way We Ride10 MotoGP Innovations That Changed The Way We Ride
msn.com - November 20 at 10:21 AM
Ten Key ValuesTen Key Values
gp.org - November 8 at 8:21 PM
2021 Mini John Cooper Works GP2021 Mini John Cooper Works GP
carbuzz.com - November 2 at 3:13 PM
Apprenticeship assessment arm of GP Strategies to closeApprenticeship assessment arm of GP Strategies to close
feweek.co.uk - November 1 at 1:26 PM
Strategies for Avoiding Holiday Weight GainStrategies for Avoiding Holiday Weight Gain
health.usnews.com - October 28 at 10:27 AM
GPX Historical DataGPX Historical Data
investing.com - October 21 at 5:52 PM
During Reading: Tasks and StrategiesDuring Reading: Tasks and Strategies
rit.edu - September 25 at 4:09 AM
GP Strategies Corporation NewsGP Strategies Corporation News
thestreet.com - September 2 at 4:22 AM
Plains GP Holdings: Healthy Financials Coupled With Upside Growth PotentialsPlains GP Holdings: Healthy Financials Coupled With Upside Growth Potentials
seekingalpha.com - August 30 at 2:14 PM
Learn How To Bet A Same-Game Parlay: Risk, Tips & StrategiesLearn How To Bet A Same-Game Parlay: Risk, Tips & Strategies
covers.com - August 22 at 7:22 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Bolt Biotherapeutics logo

Bolt Biotherapeutics

NASDAQ:BOLT
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.

Canada Zinc Metals

CVE:CZX
Canada Zinc Metals Corp. explores for and evaluates mineral resource properties in Canada. The company primarily explores for zinc-lead-silver base metals deposits. Its flagship property is the Akie property that consists of 46 mineral claims, which cover approximately 116 square kilometers, located in the Paleozoic Selwyn Basin, British Columbia. The company was formerly known as Mantle Resources Inc. and changed its name to Canada Zinc Metals Corp. in September 2008. Canada Zinc Metals Corp. was incorporated in 1988 and is headquartered in Vancouver, Canada.
First Capital Realty logo

First Capital Realty

TSE:FCR
GP Strategies logo

GP Strategies

NYSE:GPX
GP Strategies Corp. provides training, e-Learning solutions, management consulting and engineering services. It operates through the following Geographic Segments: North America, EMEA and Emerging Markets (Latin America and Asia Pacific countries). It provides Workforce Transformation Services into three primary solution sets: Organizational Performance Solutions (OPS), Technical Performance Solutions (TPS) and Automotive Performance Solutions (APS). The company was founded in 1959 and is headquartered in Columbia, MD.